Welcome to LookChem.com Sign In|Join Free

CAS

  • or
C14H11ClN2O5S is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

128924-77-6 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 128924-77-6 Structure
  • Basic information

    1. Product Name: C14H11ClN2O5S
    2. Synonyms: C14H11ClN2O5S
    3. CAS NO:128924-77-6
    4. Molecular Formula:
    5. Molecular Weight: 354.771
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 128924-77-6.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: N/A
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: C14H11ClN2O5S(CAS DataBase Reference)
    10. NIST Chemistry Reference: C14H11ClN2O5S(128924-77-6)
    11. EPA Substance Registry System: C14H11ClN2O5S(128924-77-6)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 128924-77-6(Hazardous Substances Data)

128924-77-6 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 128924-77-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,8,9,2 and 4 respectively; the second part has 2 digits, 7 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 128924-77:
(8*1)+(7*2)+(6*8)+(5*9)+(4*2)+(3*4)+(2*7)+(1*7)=156
156 % 10 = 6
So 128924-77-6 is a valid CAS Registry Number.

128924-77-6Downstream Products

128924-77-6Relevant articles and documents

Novel agents effective against solid tumors: The diarylsulfonylureas. Synthesis, activities, and analysis of quantitative structure-activity relationships

Howbert,Grossman,Crowell,Rieder,Harper,Kramer,Tao,Aikins,Poore,Rinzel,Grindey,Shaw,Todd

, p. 2393 - 2407 (2007/10/02)

A series of diarylsulfonylureas with exceptionally broad-spectrum activity against syngeneic rodent solid tumors in vivo is described. Their discovery resulted from a program dedicated to in vivo screening for novel oncolytics in solid tumor models, rather than traditional ascites leukemia models. The structures, oral efficacy, side-effect profile, and mechanism of action of these sulfonylureas appear to be distinct from previously known classes of oncolytics. An extensive series of analogues was prepared to probe structure-activity relationships (SAR), with particular focus on the substituent patterns of each aryl domain. Quantitative analysis of these substituent SARs, using the method of cluster significance analysis, showed the lipophilicity of the substituents to be the dominant determinant of activity. One compound from the series, LY186641 (104, sulofenur), has progressed to Phase I clinical trials as an antitumor drug.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 128924-77-6